Revolutionising Radiotherapy: The ORNATE Study and the Future of Breast Cancer Treatment
Description
Revolutionising Radiotherapy: The ORNATE Study and the Future of Breast Cancer Treatment with Dr Gabrielle Metz.
Dr Metz is a radiation oncologist and 2025 clinical fellow with Breast Cancer Trials. Her project, optimising radiotherapy in the neoadjuvant therapy era, also known as ORNATE, aims to refine radiotherapy for breast cancer patients receiving chemotherapy before surgery.
In this episode, we sit down with Dr Gabrielle Metz from the Royal North Shore Hospital to discuss:
- What the database is, and its role in breast cancer treatment.
- How researchers will explore whether radiation doses can be safely reduced in certain patients.
- Options for less invasive lymph node treatments.
- The future of patient outcomes in this space.
Tune in for a deep dive into this important research.
Donate to Support Life-Saving Research
Like this episode? Find more Breast Cancer Trials Podcast Episodes here
Follow Breast Cancer Trials on Social Media: Instagram: @breastcancertrials Facebook: Breast Cancer Trials LinkedIn: Breast Cancer Trials X: @BCTrialsANZ
Guest: Dr Gabrielle Metz, The Royal North Shore Hospital in Sydney.
Thank you for listening! If you found this episode valuable, please share it with your loved ones and help spread awareness about genetic testing for breast cancer.
United States
